Identification of Circulating Tumor DNA for the Early Detection of Small-cell Lung Cancer

EBioMedicine

Volumn 10, Issue , 2016, Pages 117-123

  Fernandez Cuesta, Lynnette ^a   Perdomo, Sandra ^a,b   Avogbe, Patrice H ^a   Leblay, Noemie ^a   Delhomme, Tiffany M ^a   Gaborieau, Valerie ^a   Abedi Ardekani, Behnoush ^a   Chanudet, Estelle ^a   Olivier, Magali ^a   Zaridze, David ^c   Mukeria, Anush ^c   Vilensky, Marta ^d   Holcatova, Ivana ^e   Polesel, Jerry ^f   Simonato, Lorenzo ^g   Canova, Cristina ^g   Lagiou, Pagona ^h   Brambilla, Christian ⁱ   Brambilla, Elisabeth ⁱ   Byrnes, Graham ^a   Scelo, Ghislaine ^a   Le Calvez Kelm, Florence ^a   Foll, Matthieu ^a   McKay, James D ^a   Brennan, Paul ^a   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSIDAD EL BOSQUE   (Colombia)

^c N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^d Instituto Angel Roffo   (Argentina)

^e CHARLES UNIVERSITY   (Czech Republic)

^f CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ UNIV GRENOBLE ALPES   (France)

Author keywords

cfDNA; ctDNA; Early detection; Screening; Small cell lung cancer; TP53 mutations

Indexed keywords

CELL FREE DNA; CIRCULATING TUMOR DNA; PROTEIN P53; TUMOR MARKER; UNCLASSIFIED DRUG; DNA;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DROPLET DIGITAL POLYMERASE CHAIN REACTION; EARLY CANCER DIAGNOSIS; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMALL CELL LUNG CANCER; SOMATIC MUTATION; TP53 GENE; BLOOD; CASE CONTROL STUDY; GENETICS; LEUKOCYTE; LUNG NEOPLASMS; METABOLISM; MUTATION; SMALL CELL LUNG CARCINOMA;

BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; DNA, NEOPLASM; EARLY DETECTION OF CANCER; FEMALE; HUMANS; LEUKOCYTES; LUNG NEOPLASMS; MALE; MUTATION; NEOPLASM STAGING; SMALL CELL LUNG CARCINOMA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85027949239     PISSN: None     EISSN: 23523964     Source Type: Journal    
DOI: 10.1016/j.ebiom.2016.06.032     Document Type: Article

References (40)

1. Aeberhard, W.H., Cantoni, E., Heritier, S., Robust inference in the negative binomial regression model with an application to falls data. Biometrics 70:4 (2014), 920–931.
2. Amant, F., Verheecke, M., Wlodarska, I., Dehaspe, L., Brady, P., Brison, N., Van Den Bogaert, K., Dierickx, D., Vandecaveye, V., Tousseyn, T., Moerman, P., Vanderstichele, A., Vergote, I., Neven, P., Berteloot, P., Putseys, K., Danneels, L., Vandenberghe, P., Legius, E., Vermeesch, J.R., Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 1:6 (2015), 814–819.
3. Beaver, J.A., Jelovac, D., Balukrishna, S., Cochran, R.L., Croessmann, S., Zabransky, D.J., Wong, H.Y., Valda Toro, P., Cidado, J., Blair, B.G., Chu, D., Burns, T., Higgins, M.J., Stearns, V., Jacobs, L., Habibi, M., Lange, J., Hurley, P.J., Lauring, J., VanDenBerg, D.A., Kessler, J., Jeter, S., Samuels, M.L., Maar, D., Cope, L., Cimino-Mathews, A., Argani, P., Wolff, A.C., Park, B.H., Detection of cancer DNA in plasma of patients with early-stage breast cancer. Clin. Cancer Res. 20:10 (2014), 2643–2650.
4. Benjamini, Y., Yosef, H., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol., 57(1), 1995.
5. Bettegowda, C., Sausen, M., Leary, R.J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B.R., Wang, H., Luber, B., Alani, R.M., Antonarakis, E.S., Azad, N.S., Bardelli, A., Brem, H., Cameron, J.L., Lee, C.C., Fecher, L.A., Gallia, G.L., Gibbs, P., Le, D., Giuntoli, R.L., Goggins, M., Hogarty, M.D., Holdhoff, M., Hong, S.M., Jiao, Y., Juhl, H.H., Kim, J.J., Siravegna, G., Laheru, D.A., Lauricella, C., Lim, M., Lipson, E.J., Marie, S.K.N., Netto, G.J., Oliner, K.S., Olivi, A., Olsson, L., Riggins, G.J., Sartore-Bianchi, A., Schmidt, K., Shih, l.M., Oba-Shinjo, S.M., Siena, S., Theodorescu, D., Tie, J., Harkins, T.T., Veronese, S., Wang, T.L., Weingart, J.D., Wolfgang, C.L., Wood, L.D., Xing, D., Hruban, R.H., Wu, J., Allen, P.J., Schmidt, C.M., Choti, M.A., Velculescu, V.E., Kinzler, K.W., Vogelstein, B., Papadopoulos, N., Diaz, L.A., Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci. Transl. Med., 6(224), 2014 (224ra24-224ra24).
6. Brennan, P., Wild, C.P., Genomics of cancer and a new era for cancer prevention. PLoS Genet., 11(11), 2015, e1005522.
7. Couraud, S., Vaca-Paniagua, F., Villar, S., Oliver, J., Schuster, T., Blanche, H., Girard, N., Tredaniel, J., Guilleminault, L., Gervais, R., Prim, N., Vincent, M., Margery, J., Larive, S., Foucher, P., Duvert, B., Vallee, M., Le Calvez-Kelm, F., McKay, J., Missy, P., Morin, F., Zalcman, G., Olivier, M., Souquet, P.J., Bio, C.I.-i., Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002. Clin. Cancer Res. 20:17 (2014), 4613–4624.
8. Dawson, S.-J., Tsui, D.W.Y., Murtaza, M., Biggs, H., Rueda, O.M., Chin, S.-F., Dunning, M.J., Gale, D., Forshew, T., Mahler-Araujo, B., Rajan, S., Humphray, S., Becq, J., Halsall, D., Wallis, M., Bentley, D., Caldas, C., Rosenfeld, N., Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368:13 (2013), 1199–1209.
9. Diehl, F., Schmidt, K., Choti, M.A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S.A., Kinzler, K.W., Vogelstein, B., Diaz, L.A. Jr., Circulating mutant DNA to assess tumor dynamics. Nat. Med. 14:9 (2007), 985–990.
10. Esposito, A., Bardelli, A., Criscitiello, C., Colombo, N., Gelao, L., Fumagalli, L., Minchella, I., Locatelli, M., Goldhirsch, A., Curigliano, G., Monitoring tumor-derived cell-free DNA in patients with solid tumors: clinical perspectives and research opportunities. Cancer Treat. Rev. 40:5 (2014), 648–655.
11. Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D.W.Y., Kaper, F., Dawson, S.J., Piskorz, A.M., Jimenez-Linan, M., Bentley, D., Hadfield, J., May, A.P., Caldas, C., Brenton, J.D., Rosenfeld, N., Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med., 4(136), 2012 (136ra68-136ra68).
12. Garcia-Murillas, I., Schiavon, G., Weigelt, B., Ng, C., Hrebien, S., Cutts, R.J., Cheang, M., Osin, P., Nerurkar, A., Kozarewa, I., Garrido, J.A., Dowsett, M., Reis-Filho, J.S., Smith, I.E., Turner, N.C., Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer. Sci. Transl. Med., 7(302), 2015 (302ra133).
13. Genovese, G., Kahler, A.K., Handsaker, R.E., Lindberg, J., Rose, S.A., Bakhoum, S.F., Chambert, K., Mick, E., Neale, B.M., Fromer, M., Purcell, S.M., Svantesson, O., Landen, M., Hoglund, M., Lehmann, S., Gabriel, S.B., Moran, J.L., Lander, E.S., Sullivan, P.F., Sklar, P., Gronberg, H., Hultman, C.M., McCarroll, S.A., Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371:26 (2014), 2477–2487.
14. George, J., Lim, J.S., Jang, S.J., Cun, Y., Ozretić, L., Kong, G., Leenders, F., Lu, X., Fernández-Cuesta, L., Bosco, G., Müller, C., Dahmen, I., Jahchan, N.S., Park, K.S., Yang, D., Karnezis, A.N., Vaka, D., Torres, A., Wang, M.S., Korbel, J.O., Menon, R., Chun, S.M., Kim, D., Wilkerson, M., Hayes, N., Engelmann, D., Pützer, B., Bos, M., Michels, S., Vlasic, I., Seidel, D., Pinther, B., Schaub, P., Becker, C., Altmüller, J., Yokota, J., Kohno, T., Iwakawa, R., Tsuta, K., Noguchi, M., Muley, T., Hoffmann, H., Schnabel, P.A., Petersen, I., Chen, Y., Soltermann, A., Tischler, V., Choi, C.M., Kim, Y.H., Massion, P.P., Zou, Y., Jovanovic, D., Kontic, M., Wright, G.M., Russell, P.A., Solomon, B., Koch, I., Lindner, M., Muscarella, L.A., la Torre, A., Field, J.K., Jakopovic, M., Knezevic, J., Castaños-Vélez, E., Roz, L., Pastorino, U., Brustugun, O.T., Lund-Iversen, M., Thunnissen, E., Köhler, J., Schuler, M., Botling, J., Sandelin, M., Sanchez-Cespedes, M., Salvesen, H.B., Achter, V., Lang, U., Bogus, M., Schneider, P.M., Zander, T., Ansén, S., Hallek, M., Wolf, J., Vingron, M., Yatabe, Y., Travis, W.D., Nürnberg, P., Reinhardt, C., Perner, S., Heukamp, L., Büttner, R., Haas, S.A., Brambilla, E., Peifer, M., Sage, J., Thomas, R.K., Comprehensive genomic profiles of small cell lung cancer. Nature 524:7563 (2015), 47–53.
15. Gormally, E., Vineis, P., Matullo, G., Veglia, F., Caboux, E., Le Roux, E., Peluso, M., Garte, S., Guarrera, S., Munnia, A., Airoldi, L., Autrup, H., Malaveille, C., Dunning, A., Overvad, K., Tjonneland, A., Lund, E., Clavel-Chapelon, F., Boeing, H., Trichopoulou, A., Palli, D., Krogh, V., Tumino, R., Panico, S., Bueno-de-Mesquita, H.B., Peeters, P.H., Pera, G., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J.R., Hallmans, G., Day, N.E., Key, T.J., Saracci, R., Kaaks, R., Riboli, E., Hainaut, P., TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. Cancer Res. 66:13 (2006), 6871–6876.
16. Jacobs, K.B., Yeager, M., Zhou, W., Wacholder, S., Wang, Z., Rodriguez-Santiago, B., Hutchinson, A., Deng, X., Liu, C., Horner, M.J., Cullen, M., Epstein, C.G., Burdett, L., Dean, M.C., Chatterjee, N., Sampson, J., Chung, C.C., Kovaks, J., Gapstur, S.M., Stevens, V.L., Teras, L.T., Gaudet, M.M., Albanes, D., Weinstein, S.J., Virtamo, J., Taylor, P.R., Freedman, N.D., Abnet, C.C., Goldstein, A.M., Hu, N., Yu, K., Yuan, J.M., Liao, L., Ding, T., Qiao, Y.L., Gao, Y.T., Koh, W.P., Xiang, Y.B., Tang, Z.Z., Fan, J.H., Aldrich, M.C., Amos, C., Blot, W.J., Bock, C.H., Gillanders, E.M., Harris, C.C., Haiman, C.A., Henderson, B.E., Kolonel, L.N., Le Marchand, L., McNeill, L.H., Rybicki, B.A., Schwartz, A.G., Signorello, L.B., Spitz, M.R., Wiencke, J.K., Wrensch, M., Wu, X., Zanetti, K.A., Ziegler, R.G., Figueroa, J.D., Garcia-Closas, M., Malats, N., Marenne, G., Prokunina-Olsson, L., Baris, D., Schwenn, M., Johnson, A., Landi, M.T., Goldin, L., Consonni, D., Bertazzi, P.A., Rotunno, M., Rajaraman, P., Andersson, U., Beane Freeman, L.E., Berg, C.D., Buring, J.E., Butler, M.A., Carreon, T., Feychting, M., Ahlbom, A., Gaziano, J.M., Giles, G.G., Hallmans, G., Hankinson, S.E., Hartge, P., Henriksson, R., Inskip, P.D., Johansen, C., Landgren, A., McKean-Cowdin, R., Michaud, D.S., Melin, B.S., Peters, U., Ruder, A.M., Sesso, H.D., Severi, G., Shu, X.O., Visvanathan, K., et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nat. Genet. 44:6 (2012), 651–658.
17. Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F.O., Hesch, R.D., Knippers, R., DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 61:4 (2001), 1659–1665.
18. Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P.V., Mar, B.G., Lindsley, R.C., Mermel, C.H., Burtt, N., Chavez, A., Higgins, J.M., Moltchanov, V., Kuo, F.C., Kluk, M.J., Henderson, B., Kinnunen, L., Koistinen, H.A., Ladenvall, C., Getz, G., Correa, A., Banahan, B.F., Gabriel, S., Kathiresan, S., Stringham, H.M., McCarthy, M.I., Boehnke, M., Tuomilehto, J., Haiman, C., Groop, L., Atzmon, G., Wilson, J.G., Neuberg, D., Altshuler, D., Ebert, B.L., Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371:26 (2014), 2488–2498.
19. Jamal-Hanjani, M., Wilson, G.A., Horswell, S., Mitter, R., Sakarya, O., Constantin, T., Salari, R., Kirkizlar, E., Sigurjonsson, S., Pelham, R., Kareht, S., Zimmermann, B., Swanton, C., Detection of ubiquitous and heterogeneous mutations in cell-free DNA from patients with early-stage non-small-cell lung cancer. Ann. Oncol. 27:5 (2016), 862–867.
20. Krimmel, J.D., Schmitt, M.W., Harrell, M.I., Agnew, K.J., Kennedy, S.R., Emond, M.J., Loeb, L.A., Swisher, E.M., Risques, R.A., Ultra-deep sequencing detects ovarian cancer cells in peritoneal fluid and reveals somatic TP53 mutations in noncancerous tissues. Proc. Natl. Acad. Sci. U. S. A. 113:21 (2016), 6005–6010.
21. Lagiou, P., Georgila, C., Minaki, P., Ahrens, W., Pohlabeln, H., Benhamou, S., Bouchardy, C., Slamova, A., Schejbalova, M., Merletti, F., Richiardi, L., Kjaerheim, K., Agudo, A., Castellsague, X., Macfarlane, T.V., Macfarlane, G.J., Talamini, R., Barzan, L., Canova, C., Simonato, L., Lowry, R., Conway, D.I., McKinney, P.A., Znaor, A., McCartan, B.E., Healy, C., Nelis, M., Metspalu, A., Marron, M., Hashibe, M., Brennan, P.J., Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection. Eur. J. Cancer Prev. 18:1 (2009), 76–84.
22. Laurie, C.C., Laurie, C.A., Rice, K., Doheny, K.F., Zelnick, L.R., McHugh, C.P., Ling, H., Hetrick, K.N., Pugh, E.W., Amos, C., Wei, Q., Wang, L.E., Lee, J.E., Barnes, K.C., Hansel, N.N., Mathias, R., Daley, D., Beaty, T.H., Scott, A.F., Ruczinski, I., Scharpf, R.B., Bierut, L.J., Hartz, S.M., Landi, M.T., Freedman, N.D., Goldin, L.R., Ginsburg, D., Li, J., Desch, K.C., Strom, S.S., Blot, W.J., Signorello, L.B., Ingles, S.A., Chanock, S.J., Berndt, S.I., Le Marchand, L., Henderson, B.E., Monroe, K.R., Heit, J.A., de Andrade, M., Armasu, S.M., Regnier, C., Lowe, W.L., Hayes, M.G., Marazita, M.L., Feingold, E., Murray, J.C., Melbye, M., Feenstra, B., Kang, J.H., Wiggs, J.L., Jarvik, G.P., McDavid, A.N., Seshan, V.E., Mirel, D.B., Crenshaw, A., Sharopova, N., Wise, A., Shen, J., Crosslin, D.R., Levine, D.M., Zheng, X., Udren, J.I., Bennett, S., Nelson, S.C., Gogarten, S.M., Conomos, M.P., Heagerty, P., Manolio, T., Pasquale, L.R., Haiman, C.A., Caporaso, N., Weir, B.S., Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat. Genet. 44:6 (2012), 642–650.
23. Martincorena, I., Campbell, P.J., Somatic mutation in cancer and normal cells. Science 349:6255 (2015), 1483–1489.
24. Murtaza, M., Dawson, S.-J., Tsui, D.W.Y., Gale, D., Forshew, T., Piskorz, A.M., Parkinson, C., Chin, S.-F., Kingsbury, Z., Wong, A.S.C., Marass, F., Humphray, S., Hadfield, J., Bentley, D., Chin, T.M., Brenton, J.D., Caldas, C., Rosenfeld, N., Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497:7447 (2013), 108–112.
25. Newman, A.M., Bratman, S.V., To, J., Wynne, J.F., Eclov, N.C.W., Modlin, L.A., Liu, C.L., Neal, J.W., Wakelee, H.A., Merritt, R.E., Shrager, J.B., Loo, B.W., Alizadeh, A.A., Diehn, M., An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 20:5 (2014), 548–554.
26. Nicholson, A.G., Chansky, K., Crowley, J., Beyruti, R., Kubota, K., Turrisi, A., Eberhardt, W.E., van Meerbeeck, J., Rami-Porta, R., Staging and Prognostic Factors Committee, A. v. B., and Participating Institutions & Institutions, S. a. P. F. C. A. B. a. P., The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer. J. Thorac. Oncol. 11:3 (2016), 300–311.
27. Peifer, M., Fernández-Cuesta, L., Sos, M.L., George, J., Seidel, D., Kasper, L.H., Plenker, D., Leenders, F., Sun, R., Zander, T., Menon, R., Koker, M., Dahmen, I., Müller, C., Di Cerbo, V., Schildhaus, H.U., Altmüller, J., Baessmann, I., Becker, C., de Wilde, B., Vandesompele, J., Böhm, D., Ansén, S., Gabler, F., Wilkening, I., Heynck, S., Heuckmann, J.M., Lu, X., Carter, S.L., Cibulskis, K., Banerji, S., Getz, G., Park, K.S., Rauh, D., Grütter, C., Fischer, M., Pasqualucci, L., Wright, G., Wainer, Z., Russell, P., Petersen, I., Chen, Y., Stoelben, E., Ludwig, C., Schnabel, P., Hoffmann, H., Muley, T., Brockmann, M., Engel-Riedel, W., Muscarella, L.A., Fazio, V.M., Groen, H., Timens, W., Sietsma, H., Thunnissen, E., Smit, E., Heideman, D.A., Snijders, P.J., Cappuzzo, F., Ligorio, C., Damiani, S., Field, J., Solberg, S., Brustugun, O.T., Lund-Iversen, M., Sänger, J., Clement, J.H., Soltermann, A., Moch, H., Weder, W., Solomon, B., Soria, J.C., Validire, P., Besse, B., Brambilla, E., Brambilla, C., Lantuejoul, S., Lorimier, P., Schneider, P.M., Hallek, M., Pao, W., Meyerson, M., Sage, J., Shendure, J., Schneider, R., Büttner, R., Wolf, J., Nürnberg, P., Perner, S., Heukamp, L.C., Brindle, P.K., Haas, S., Thomas, R.K., Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet. 44:10 (2012), 1104–1110.
28. Ribeiro, K.B., Levi, J.E., Pawlita, M., Koifman, S., Matos, E., Eluf-Neto, J., Wunsch-Filho, V., Curado, M.P., Shangina, O., Zaridze, D., Szeszenia-Dabrowska, N., Lissowska, J., Daudt, A., Menezes, A., Bencko, V., Mates, D., Fernandez, L., Fabianova, E., Gheit, T., Tommasino, M., Boffetta, P., Brennan, P., Waterboer, T., Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int. J. Epidemiol. 40:2 (2011), 489–502.
29. Roschewski, M., Dunleavy, K., Pittaluga, S., Moorhead, M., Pepin, F., Kong, K., Shovlin, M., Jaffe, E.S., Staudt, L.M., Lai, C., Steinberg, S.M., Chen, C.C., Zheng, J., Willis, T.D., Faham, M., Wilson, W.H., Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study. Lancet Oncol. 16:5 (2015), 541–549.
30. Rudin, C.M., Durinck, S., Stawiski, E.W., Poirier, J.T., Modrusan, Z., Shames, D.S., Bergbower, E.A., Guan, Y., Shin, J., Guillory, J., Rivers, C.S., Foo, C.K., Bhatt, D., Stinson, J., Gnad, F., Haverty, P.M., Gentleman, R., Chaudhuri, S., Janakiraman, V., Jaiswal, B.S., Parikh, C., Yuan, W., Zhang, Z., Koeppen, H., Wu, T.D., Stern, H.M., Yauch, R.L., Huffman, K.E., Paskulin, D.D., Illei, P.B., Varella-Garcia, M., Gazdar, A.F., de Sauvage, F.J., Bourgon, R., Minna, J.D., Brock, M.V., Seshagiri, S., Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet. 44:10 (2012), 1111–1116.
31. Sausen, M., Phallen, J., Adleff, V., Jones, S., Leary, R.J., Barrett, M.T., Anagnostou, V., Parpart-Li, S., Murphy, D., Kay Li, Q., Hruban, C.A., Scharpf, R., White, J.R., O'Dwyer, P.J., Allen, P.J., Eshleman, J.R., Thompson, C.B., Klimstra, D.S., Linehan, D.C., Maitra, A., Hruban, R.H., Diaz, L.A. Jr., Von Hoff, D.D., Johansen, J.S., Drebin, J.A., Velculescu, V.E., Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients. Nat. Commun., 6, 2015, 7686.
32. Schwarzenbach, H., Hoon, D.S.B., Pantel, K., Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11:6 (2011), 426–437.
33. Siravegna, G., Mussolin, B., Buscarino, M., Corti, G., Cassingena, A., Crisafulli, G., Ponzetti, A., Cremolini, C., Amatu, A., Lauricella, C., Lamba, S., Hobor, S., Avallone, A., Valtorta, E., Rospo, G., Medico, E., Motta, V., Antoniotti, C., Tatangelo, F., Bellosillo, B., Veronese, S., Budillon, A., Montagut, C., Racca, P., Marsoni, S., Falcone, A., Corcoran, R.B., Di Nicolantonio, F., Loupakis, F., Siena, S., Sartore-Bianchi, A., Bardelli, A., Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients. Nat. Med. 21:7 (2015), 795–801.
34. Stroun, M., Maurice, P., Vasioukhin, V., Lyautey, J., Lederrey, C., Lefort, F., Rossier, A., Chen, X.Q., Anker, P., The origin and mechanism of circulating DNA. Ann. N. Y. Acad. Sci. 906 (2000), 161–168.
35. The Lancet Oncology, Liquid cancer biopsy: the future of cancer detection?. Lancet Oncol., 17(2), 2016, 123.
36. Wentzensen, N., Wacholder, S., From differences in means between cases and controls to risk stratification: a business plan for biomarker development. Cancer Discov. 3:2 (2013), 148–157.
37. Wong, T.N., Ramsingh, G., Young, A.L., Miller, C.A., Touma, W., Welch, J.S., Lamprecht, T.L., Shen, D., Hundal, J., Fulton, R.S., Heath, S., Baty, J.D., Klco, J.M., Ding, L., Mardis, E.R., Westervelt, P., DiPersio, J.F., Walter, M.J., Graubert, T.A., Ley, T.J., Druley, T.E., Link, D.C., Wilson, R.K., Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature 518:7540 (2015), 552–555.
38. Wozniak, M.B., Scelo, G., Muller, D.C., Mukeria, A., Zaridze, D., Brennan, P., Circulating microRNAs as non-invasive biomarkers for early detection of non-small-cell lung cancer. PLoS One, 10(5), 2015, e0125026.
39. Xie, M., Lu, C., Wang, J., McLellan, M.D., Johnson, K.J., Wendl, M.C., McMichael, J.F., Schmidt, H.K., Yellapantula, V., Miller, C.A., Ozenberger, B.A., Welch, J.S., Link, D.C., Walter, M.J., Mardis, E.R., Dipersio, J.F., Chen, F., Wilson, R.K., Ley, T.J., Ding, L., Age-related mutations associated with clonal hematopoietic expansion and malignancies. Nat. Med. 20:12 (2014), 1472–1478.
40. Yang, H., Wang, K., Genomic variant annotation and prioritization with ANNOVAR and wANNOVAR. Nat. Protoc. 10:10 (2015), 1556–1566.